NCT05321082: An ongoing trial by Boehringer Ingelheim
This trial is ongoing. It must report results 2 days, 21 hours from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05321082 |
|---|---|
| Title | A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 16, 2022 |
| Completion date | Dec. 18, 2024 |
| Required reporting date | Dec. 18, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |